Access to and utilization of primary care services among HIV-infected women

被引:58
作者
Palacio, H
Shiboski, CH
Yelin, EH
Hessol, NA
Greenblatt, RM
机构
[1] Univ Calif San Francisco, Sch Med, AIDS Program, San Francisco Gen Hosp,Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Sch Dent, Dept Stomatol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Sch Med, Div Rheumatol, Dept Med, San Francisco, CA USA
[4] Univ Calif San Francisco, Sch Med, Div Infect Dis, Dept Med, San Francisco, CA USA
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1999年 / 21卷 / 04期
关键词
health services use; HIV infections; female; cohort studies; ambulatory care;
D O I
10.1097/00126334-199908010-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To identify factors associated with the use of medical services, and to test a model of access to care, among HIV-infected women. Methods: A cross-sectional telephone survey was administered to 213 HIV-infected women. Outcomes were having a primary care provider, and use of primary care and emergency health services. Predictors included characteristics of the population-at-risk and of the health care system. Results: Ninety-three percent of respondents had a primary care provider. Linear regression found age >45 years (p = .002), perceiving greater barriers to getting to a clinic (p = .04) and greater benefits from medications (p = .03), lack of problems with appointment times (p = .02), having AIDS (p = .01), shorter appointment waiting rimes (p = .0003), and greater cost of travel to care (p = .001) were associated with a greater number of primary care visits. Thirty-seven percent missed at least 1 primary care appointment. In logistic regression, lack of insurance (odds ratio [OR] = 2.76), current injection drug use (OR = 2.89) and difficulty remembering appointments (OR = 2.36) were associated with having missed any appointments. Conclusions: Characteristics of the population-at-risk and of the health care system both make important contributions to primary care service use.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 40 条
[11]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[12]  
*CDCP, 1999, CDC AIDS PUBL INF DA
[13]  
Centers for Disease Control and Prevention, 1997, HIV AIDS SURVEILLANC, V9, P1
[14]  
DEEKS SG, 1998, AIDS KNOWLEDGE BASE
[15]  
FLEISHMAN JA, 1994, HEALTH SERV RES, V29, P527
[16]  
FLEISHMAN JA, 1993, INQUIRY-J HEALTH CAR, V30, P180
[17]  
GIELEN AC, 1994, AIDS EDUC PREV, V6, P1
[18]   ACCESS TO THERAPY IN THE MULTICENTER AIDS COHORT STUDY, 1989-1992 [J].
GRAHAM, NMH ;
JACOBSON, LP ;
KUO, V ;
CHMIEL, JS ;
MORGENSTERN, H ;
ZUCCONI, SL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (09) :1003-1012
[19]  
GREENBLATT RM, 1991, J ACQ IMMUN DEF SYND, V4, P136
[20]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733